Micro RNA 100 sensitizes luminal A breast cancer cells to paclitaxel treatment in part by targeting mTOR

Luminal A breast cancer usually responds to hormonal therapies but does not benefit from chemotherapies, including microtubule-targeted paclitaxel. MicroRNAs could play a role in mediating this differential response. In this study, we examined the role of micro RNA 100 (miR-100) in the sensitivity o...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Baotong, Zhao, Ranran, He, Yuan, Fu, Xing, Fu, Liya, Zhu, Zhengmao, Fu, Li, Dong, Jin-Tang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868715/
https://www.ncbi.nlm.nih.gov/pubmed/26744318
http://dx.doi.org/10.18632/oncotarget.6790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868715/
https://www.ncbi.nlm.nih.gov/pubmed/26744318
http://dx.doi.org/10.18632/oncotarget.6790

Ejemplares similares